Eur J Pediatr Surg
DOI: 10.1055/s-0044-1791801
Original Article

The Role of GERD Diagnosis and Treatment in Preventing Lung Function Decline After Pediatric Lung Transplantation

Elena Chiara Garrisi
1   Department of Pediatric Surgery, Hannover Medical School, Hannover, Germany
,
Carsten Müller
2   Department of Pediatric Pneumology, Allergology and Neonatology, Hannover Medical School, Hannover, Germany
,
Benno Ure
1   Department of Pediatric Surgery, Hannover Medical School, Hannover, Germany
,
Julia Carlens
2   Department of Pediatric Pneumology, Allergology and Neonatology, Hannover Medical School, Hannover, Germany
,
1   Department of Pediatric Surgery, Hannover Medical School, Hannover, Germany
,
Nagoud Schukfeh
1   Department of Pediatric Surgery, Hannover Medical School, Hannover, Germany
› Author Affiliations


Abstract

Background/Purpose Gastroesophageal reflux disease (GERD) after lung transplantation (LuTx) can lead to chronic lung allograft dysfunction. Our aim was to assess the prevalence of GERD in pediatric LuTx recipients and to investigate the impact of medical and surgical GERD treatment on lung function.

Methods Ethical approval was obtained. Data of all consecutive patients who underwent LuTx from 2013 to 2023 and aged < 18 years at the time of the study were prospectively collected. A GERD diagnostic algorithm was established, including assessment of symptoms (vomiting, heartburn, regurgitation, cough, recurrent airway infections), bronchoscopy, forced expiratory volume in 1 second, and pH impedance. Further investigations included upper gastrointestinal series and esophagogastroduodenoscopy. Patients with GERD underwent medical treatment or fundoplication. Lung function was monitored.

Results Thirty-six patients (2 months–18 years, 50% male) were included. Twenty-nine (80%) underwent spirometry, 16 (45%) pH impedance study, and 14 (39%) esophagogastroduodenoscopy. Twenty-two (61%) had no GERD symptoms and 12 (33%) showed normal pH impedance study or esophagogastroduodenoscopy. Fourteen (39%) patients had GERD symptoms, all 9 tested symptomatic patients (25%) had pathological GERD-specific diagnostics. Three (8%) patients underwent fundoplication after a median of 1.6 years (range 1.1–5.7 years) post-LuTx without surgical complications. After a median follow-up of 2.3 years (range 1.3–2.8 years) post-fundoplication, all (n = 3) had complete remission of GERD symptoms and lung function improvement. Lung function decline was observed in 6 (67%) of the tested symptomatic patients on proton-pump inhibitors (PPIs) treatment.

Conclusion Over one-third of our patients presented with GERD symptoms after LuTx. Symptoms and lung function may be reliable GERD indicators. Given the high prevalence of GERD, we suggest a routine posttransplant diagnostic algorithm including pH impedance study. Eighty percent of all symptomatic patients had a lung function decline despite PPI. Fundoplication is safe and may improve long-term outcome in pediatric LuTx recipients.



Publication History

Received: 08 May 2024

Accepted: 23 September 2024

Article published online:
17 October 2024

© 2024. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Venuta F, Van Raemdonck D. History of lung transplantation. J Thorac Dis 2017; 9 (12) 5458-5471
  • 2 Patel A, Faro A. Pediatric lung transplantation. Pediatric Respiratory Diseases 2020; 761-775
  • 3 Meyer KC, Raghu G, Verleden GM. et al; ISHLT/ATS/ERS BOS Task Force Committee, ISHLT/ATS/ERS BOS Task Force Committee. An international ISHLT/ATS/ERS clinical practice guideline: diagnosis and management of bronchiolitis obliterans syndrome. Eur Respir J 2014; 44 (06) 1479-1503
  • 4 Abbassi-Ghadi N, Kumar S, Cheung B. et al. Anti-reflux surgery for lung transplant recipients in the presence of impedance-detected duodenogastroesophageal reflux and bronchiolitis obliterans syndrome: a study of efficacy and safety. J Heart Lung Transplant 2013; 32 (06) 588-595
  • 5 Estenne M, Maurer JR, Boehler A. et al. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant 2002; 21 (03) 297-310
  • 6 Hoppo T, Jarido V, Pennathur A. et al. Antireflux surgery preserves lung function in patients with gastroesophageal reflux disease and end-stage lung disease before and after lung transplantation. Arch Surg 2011; 146 (09) 1041-1047
  • 7 Davis Jr RD, Lau CL, Eubanks S. et al. Improved lung allograft function after fundoplication in patients with gastroesophageal reflux disease undergoing lung transplantation. J Thorac Cardiovasc Surg 2003; 125 (03) 533-542
  • 8 Robertson AG, Krishnan A, Ward C. et al. Anti-reflux surgery in lung transplant recipients: outcomes and effects on quality of life. Eur Respir J 2012; 39 (03) 691-697
  • 9 Davidson JR, Franklin D, Kumar S. et al. Fundoplication to preserve allograft function after lung transplant: systematic review and meta-analysis. J Thorac Cardiovasc Surg 2020; 160 (03) 858-866
  • 10 Zheng C, Kane TD, Kurland G. et al. Feasibility of laparoscopic Nissen fundoplication after pediatric lung or heart-lung transplantation: should this be the standard?. Surg Endosc 2011; 25 (01) 249-254
  • 11 Jamie Dy F, Freiberger D, Liu E, Boyer D, Visner G, Rosen R. Impact of gastroesophageal reflux and delayed gastric emptying on pediatric lung transplant outcomes. J Heart Lung Transplant 2017; 36 (08) 854-861
  • 12 Benden C, Aurora P, Curry J, Whitmore P, Priestley L, Elliott MJ. High prevalence of gastroesophageal reflux in children after lung transplantation. Pediatr Pulmonol 2005; 40 (01) 68-71
  • 13 Hopkins PM, Kermeen F, Duhig E. et al. Oil red O stain of alveolar macrophages is an effective screening test for gastroesophageal reflux disease in lung transplant recipients. J Heart Lung Transplant 2010; 29 (08) 859-864
  • 14 Furuya ME, Moreno-Córdova V, Ramírez-Figueroa JL, Vargas MH, Ramón-García G, Ramírez-San Juan DH. Cutoff value of lipid-laden alveolar macrophages for diagnosing aspiration in infants and children. Pediatr Pulmonol 2007; 42 (05) 452-457
  • 15 Ahrens P, Noll C, Kitz R, Willigens P, Zielen S, Hofmann D. Lipid-laden alveolar macrophages (LLAM): a useful marker of silent aspiration in children. Pediatr Pulmonol 1999; 28 (02) 83-88
  • 16 Wenzl TG, Benninga MA, Loots CM, Salvatore S, Vandenplas Y. ESPGHAN EURO-PIG Working Group. Indications, methodology, and interpretation of combined esophageal impedance-pH monitoring in children: ESPGHAN EURO-PIG standard protocol. J Pediatr Gastroenterol Nutr 2012; 55 (02) 230-234
  • 17 Pilic D, Fröhlich T, Nöh F. et al. Detection of gastroesophageal reflux in children using combined multichannel intraluminal impedance and pH measurement: data from the German Pediatric Impedance Group. J Pediatr 2011; 158 (04) 650-654.e1
  • 18 Gunasagaran HL, Varjavandi V, Lemberg DA, Ooi CY, Gupta N, Krishnan U. The utility of multichannel intraluminal impedance-pH testing in tailoring the management of paediatric gastro-oesophageal reflux disease. Acta Paediatr 2020; 109 (12) 2799-2807
  • 19 Zerbib F, des Varannes SB, Roman S. et al. Normal values and day-to-day variability of 24-h ambulatory oesophageal impedance-pH monitoring in a Belgian-French cohort of healthy subjects. Aliment Pharmacol Ther 2005; 22 (10) 1011-1021
  • 20 Sifrim D, Castell D, Dent J, Kahrilas PJ. Gastro-oesophageal reflux monitoring: review and consensus report on detection and definitions of acid, non-acid, and gas reflux. Gut 2004; 53 (07) 1024-1031
  • 21 Sifrim D, Holloway R, Silny J. et al. Acid, nonacid, and gas reflux in patients with gastroesophageal reflux disease during ambulatory 24-hour pH-impedance recordings. Gastroenterology 2001; 120 (07) 1588-1598
  • 22 Roy-Choudhury S, Ashcraft KW. Thal fundoplication for pediatric gastroesophageal reflux disease. Semin Pediatr Surg 1998; 7 (02) 115-120
  • 23 International Thoracic Organ Transplant (TTX) Registry Data Slides. 2024 . Accessed May 3, 2024 at: https://ishltregistries.org/registries/slides.asp?yearToDisplay=2019
  • 24 Burton PR, Button B, Brown W. et al. Medium-term outcome of fundoplication after lung transplantation. Dis Esophagus 2009; 22 (08) 642-648
  • 25 Pegna V, Mickevičius A, Tsang C. How useful is antireflux surgery in lung transplant patients with gastroesophageal reflux?. Medicina (Kaunas) 2014; 50 (06) 318-322
  • 26 D'Ovidio F, Mura M, Ridsdale R. et al. The effect of reflux and bile acid aspiration on the lung allograft and its surfactant and innate immunity molecules SP-A and SP-D. Am J Transplant 2006; 6 (08) 1930-1938
  • 27 Cantu III E, Appel III JZ, Hartwig MG. et al. J. Maxwell Chamberlain Memorial Paper. Early fundoplication prevents chronic allograft dysfunction in patients with gastroesophageal reflux disease. Ann Thorac Surg 2004; 78 (04) 1142-1151 , discussion 1142–1151
  • 28 Robinson PD, Spencer H, Aurora P. Impact of lung function interpretation approach on pediatric bronchiolitis obliterans syndrome diagnosis after lung transplantation. J Heart Lung Transplant 2015; 34 (08) 1082-1088
  • 29 Thompson BR, Westall GP, Paraskeva M, Snell GI. Lung transplantation in adults and children: putting lung function into perspective. Respirology 2014; 19 (08) 1097-1105